US FDA approves GSK units drug to treat infants and children with HIV – The Business Times

Sat, Jun 13, 2020 – 8:20 AM

[BENGALURU] The US Meals and Drug Administration has authorised a drug to deal with infants and youngsters with HIV, with the drug having been developed by drugmaker GlaxoSmithKline’s HIV medication division ViiV Healthcare, the FDA and the GSK unit stated.

The FDA stated on Friday it was granting Viiv the approval of Tivicay and Tivicay PD tablets “for suspension to deal with HIV-1 an infection in pediatric sufferers no less than 4 weeks outdated and weighing no less than three kilograms together with different antiretroviral therapies”.

The drug is at the moment below evaluation by the European Medicines Company, ViiV, wherein Pfizer and Shionogi have small stakes, stated in a separate assertion.



Leave a Reply

Your email address will not be published. Required fields are marked *

Copyright 2020